Alopecia Treatment (Hair Loss) Market will reach USD 6,266.73 Million by 2030

Published July 21, 2023

Global Alopecia Treatment (Hair Loss) Market report the data and realities of the Healthcare industry can be focused which keeps business on the right path. All the parameters covered here are of immense use to analyse market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, and distributors. In addition, the company profile, product specifications, capacity, production value, and market shares for each company for the forecast period can also be achieved with this report. Global Alopecia Treatment (Hair Loss) Market research report is a careful investigation of current scenario of the market and future estimations which deals with several market dynamics.

Alopecia Treatment (Hair Loss) Market

Hair loss is on the rise due to poor eating patterns and sedentary lifestyles with each passing decade. In addition, aging, hormonal imbalance, and an increase in chronic diseases like cancer, hypertension, arthritis, and depression, particularly in the middle-aged population, all contribute to hair loss. Nearly 95% of men’s hair loss is caused by androgenetic alopecia, according to the American Hair Loss Association. Over 800,000 people worldwide are looking for a cure for hair loss, thus the market sees a surge in technology and treatment in the market in the mentioned forecast period.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @

Data Bridge Market Research analyses that the alopecia treatment (hair loss) market, valued at USD 3,614.73 million in 2022, will reach USD 6,266.73 million by 2030, growing at a CAGR of 7.12% during the forecast period of 2023 to 2030.  In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Alopecia is a type of hair loss brought on by specific medical conditions or dietary problems. Sedentary lifestyles and poor eating habits are contributing to an increase in hair loss. In addition, aging, hormonal imbalance, and an increase in chronic diseases like cancer, hypertension, arthritis, and depression, particularly in the middle-aged population, all contribute to hair loss.


  • Increasing prevalence of alopecia drives the market

The increasing prevalence of alopecia, encompassing conditions like androgenetic alopecia and alopecia areata, is a key driver for the alopecia treatment market. Factors such as genetic predisposition, hormonal imbalances, stress, and lifestyle changes contribute to the rising incidence of hair loss worldwide. As more individuals experience hair loss, there is a growing demand for effective treatment options to address this concern. This drives market growth as pharmaceutical companies and healthcare providers focus on developing and offering innovative solutions to meet the needs of the growing patient population seeking treatment for various forms of alopecia.

  • Aging population drives the market

The aging population is a significant driver for the growth of the alopecia treatment market. Hair loss is commonly associated with aging, and as the global population continues to age, the prevalence of age-related hair loss is expected to increase. With more individuals in older age groups experiencing hair loss, there is a greater demand for effective treatment options to address this concern. This demographic trend provides an opportunity for pharmaceutical companies and healthcare providers to develop and offer specialized treatments tailored to the unique needs of the aging population, driving the expansion of the alopecia treatment market.


  • High treatment costs impede the market growth

The high treatment costs associated with certain alopecia treatment options, like hair transplant procedures, act as a significant restraint on market growth. The expense of these treatments can deter individuals from seeking professional help, especially those with limited financial resources. Inaccessibility due to high costs prevents a substantial portion of the population from accessing effective treatments, limiting market growth potential.

  • Limited effectiveness of treatments restricts the market growth

The limited effectiveness of alopecia treatments is a significant restraint on market growth. Despite the availability of various treatment options, the outcomes can vary widely among individuals. Some may experience minimal or no regrowth of hair, leading to dissatisfaction and reduced trust in treatment efficacy. This limitation hinders market growth as individuals may become hesitant to invest in treatments that may not deliver satisfactory results.

  • Side effects and safety concerns limit the market growth

Side effects and safety concerns associated with alopecia treatments present a significant restraint on market growth. Medications like minoxidil and finasteride, commonly used for hair loss, can cause scalp irritation or other adverse reactions in certain individuals. These potential side effects raise safety concerns and may discourage individuals from pursuing treatment or continuing its use. For the market to expand, patient trust in the safety and acceptability of treatments is essential.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the alopecia treatment (hair loss) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2021, Ritlecitinib’s successful phase 2b/3 trial for the treatment of alopecia was announced by Pfizer. The Janus kinase 3 (JAK3) and members of the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family are the first targets of a new class of covalent kinase inhibitors, which include ritlecitinib. Ritlecitinib is being tested as a treatment for alopecia to stop the immune cells and signaling molecules that are a major cause of hair loss from functioning.

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@

Top Key Topics Covered:

  1. Strategic Imperatives
  • Factors Creating Pressure on Growth
  • The Strategic Imperative
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology
  1. Scope and Segmentation
  • Research Context and Scope of Analysis
  • Segmentation
  • Other Techniques for This Research Report Management
  1. Growth Opportunity Analysis
  • Growth Drivers
  • Growth Restraints
  1. Introduction
  • The Impact of the COVID-19 Pandemic and Post
  • Future Growth
  1. Innovation Ecosystem


Alopecia Treatment (Hair Loss) Market Scope

The alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, drug type, gender, age group, form, distribution channel, and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

  • Alopecia Areata
  • Cicatricial
  • Traction
  • Androgenetic Alopecia
  • Non‒Cicatricial Alopecia
  • Traction Alopecia
  • Ciatricial Alopecia
  • Alopecia Totalis
  • Alopecia Universalis
  • Others


  • Localized Therapies
  • Medical Devices
  • Systemic Therapies
  • Herbal Treatment
  • Hair Transplant Services
  • Low Level Laser Therapy

Drug Type

  • Topical Agents
  • Creams
  • Oils
  • Gels
  • Shampoo
  • Lotion
  • Foam
  • Oral Drugs
  • Injections
  • Platelet Rich Plasma
  • Steroid Injections
  • Injectable Filler
  • Corticosteroids
  • Immunosuppressants
  • Minoxidil
  • Finasteride
  • Others


  • Male
  • Female

Age Group

  • Below 18 Years
  • 18-34 Years
  • 35-49 Years
  • Above 50 Years


  • Topical
  • Oral
  • Parenteral

Distribution Channel

  • Hospital Pharmacy
  • Drug Stores
  • Dermatology Clinics
  • Retail Pharmacy
  • Online Pharmacy
  • Others


  • Hospitals
  • Dermatologic and Trichology Clinics
  • Aesthetic Clinics
  • Specialty Clinics
  • Homecare
  • Others

Fundamental Aim of this Market Report

  • Notable Market rivals around the world.
  • Future Scope and Product Outlook
  • Future-promising emerging markets.
  • The Market Presents Difficult Challenges and Threats.

Key highlights of this Market report:

  • Major restraints
  • Market drivers
  • Regional bifurcation
  • Competitive hierarchy
  • Current market tendencies
  • Market concentration analysis

Browse the complete table of contents at –

Some of the major players operating in the alopecia treatment (hair loss) market are:

  • Johnson & Johnson Private Limited (U.S.)
  • GlaxoSmithKline plc U.K.)
  • Merck & Co., Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Cipla Inc. (India)
  • Endo International plc (Ireland)
  • Zydus Group (India)
  • Abbott (U.S.)
  • Aurobindo Pharma (India)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Perrigo Company plc (Ireland)
  • Curallux, LLC. (U.S.)
  • DR. KURT WOLFF GMBH & CO. KG (Germany)
  • WockhardtHospitals (India)
  • Sun Pharmaceutical Industries Ltd.(India)
  • Concert Pharmaceuticals. (U.S.)
  • Cipla Inc. (India)

Critical Insights Related to the adalimumab biosimilar Included in the Report:

    • Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
    • Value chain analysis of prominent players in the market
    • Current trends influencing the dynamics of this market across various geographies
    • Recent mergers, acquisitions, collaborations, and partnerships
    • Revenue growth of this industry over the forecast period
    • Marketing strategy study and growth trends
    • Growth-driven factor analysis
    • Emerging recess segments and region-wise market
    • An empirical evaluation of the curve of this market
    • Ancient, Present, and Probable scope of the market from both prospect value and volume

Top DBMR Healthcare Reports:

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


CDN Newswire